Real-time enrollment status for this hiv-1 infection clinical trial
Current Status
Recruiting
Checked: April 16, 2026 at 11:16 PM UTC
| NCT Number | NCT05869643 |
| Recruiting Status | Recruiting |
| Condition | HIV-1 Infection |
| Phase | Clinical Trial |
| Target Enrollment | 36 participants |
| Active Locations | 13 sites in the US |
| Sponsor | ST Pharm Co., Ltd. |
| Last Updated on CT.gov | March 11, 2026 (Mar 11, 2026) |
As of April 16, 2026: Clinical trial NCT05869643 is currently recruiting participants. This clinical trial study for hiv-1 infection is actively seeking new participants at 13 locations across the United States. The study is sponsored by ST Pharm Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05869643 is actively recruiting participants as of April 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05869643 was last updated Mar 11, 2026 (March 11, 2026). HelloStudys verifies this status automatically.